Neogenomics (NEO) Current Leases (2010 - 2026)

Neogenomics (NEO) has reported Current Leases for 17 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

• Current Leases for Q1 2026 came in at $4.8 million, up 57.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 57.01% YoY), and the FY2025 annual result was $4.8 million, up 41.26% from the prior year.
• Current Leases was $4.8 million for Q1 2026 at Neogenomics, up from $4.8 million in the prior quarter.
• Over five years, Current Leases peaked at $7.4 million in Q2 2023 and troughed at $4000.0 in Q3 2023.
• Average Current Leases over 5 years is $3.7 million, with a median of $4.1 million recorded in 2025.
• Year-over-year, Current Leases sank 98.31% in 2022 and surged 92800.0% in 2024.
• Over 5 years, Current Leases stood at $70000.0 in 2022, then soared by 7914.29% to $5.6 million in 2023, then slumped by 39.73% to $3.4 million in 2024, then surged by 41.26% to $4.8 million in 2025, then gained by 1.09% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $4.8 million in Q1 2026, $4.8 million in Q4 2025, and $4.5 million in Q3 2025.